The RhoJ-BAD signaling network: An Achilles' heel for BRAF mutant melanomas.
Genes and pathways that allow cells to cope with oncogene-induced stress represent selective cancer therapeutic targets that remain largely undiscovered. In this study, we identify a RhoJ signaling pathway that is a selective therapeutic target for BRAF mutant cells. RhoJ deletion in BRAF mutant mel...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-07-01
|
Series: | PLoS Genetics |
Online Access: | http://europepmc.org/articles/PMC5549996?pdf=render |